A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)

NCT02614716 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Sjögren's Syndrome

Interventions

DRUG: LY3090106
DRUG: Placebo

Sponsor

Eli Lilly and Company